Literature DB >> 12482558

Sequence and functional changes in a putative enhancer region upstream of the apolipoprotein(a) gene.

Loretto H Puckey1, Brian L Knight.   

Abstract

Two enhancer regions upstream of the apolipoprotein(a) (apo(a)) gene were amplified and sequenced from subjects who were known to express abnormally high or low amounts of lipoprotein(a) (Lp(a)). No base changes were found in the DHII region situated 28 kb from the apo(a) gene. Three common base substitutions were found in the DHIII region about 20 kb from the gene. One, an A to G change at position -1230, increased the activity of reporter-gene constructs approximately 2.5-fold. The other two, a C to A change at -1617 and a G to T change at -1712, decreased reporter activity by 30 and 40%, respectively. The sites at -1230 and -1617 were in linkage disequilibrium with each other and also with a polymorphic site near the DHII enhancer and sites in the apo(a) promoter and gene. The rarer G variant at -1230 was associated with smaller alleles. After correcting for the effect of allele size, values of Lp(a) concentration for alleles associated with the G variant at -1230 were 70% higher than those associated with the more common A variant. In contrast, the corrected values for alleles associated with the rare T variant at -1712 were 40% lower than those associated with the common G variant. Thus, overall the changes observed in this enhancer could influence apo(a) gene transcription up to 4-fold and could provide a significant contribution to the variation in Lp(a) concentrations in plasma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12482558     DOI: 10.1016/s0021-9150(02)00315-5

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  10 in total

1.  Genome-wide association study of plasma lipoprotein(a) levels identifies multiple genes on chromosome 6q.

Authors:  Carole Ober; Alex S Nord; Emma E Thompson; Lin Pan; Zheng Tan; Darren Cusanovich; Ying Sun; Raluca Nicolae; Celina Edelstein; Daniel H Schneider; Christine Billstrand; Ditta Pfaffinger; Natasha Phillips; Rebecca L Anderson; Binu Philips; Ramakrishnan Rajagopalan; Thomas S Hatsukami; Mark J Rieder; Patrick J Heagerty; Deborah A Nickerson; Mark Abney; Santica Marcovina; Gail P Jarvik; Angelo M Scanu; Dan L Nicolae
Journal:  J Lipid Res       Date:  2009-01-05       Impact factor: 5.922

Review 2.  Structure, function, and genetics of lipoprotein (a).

Authors:  Konrad Schmidt; Asma Noureen; Florian Kronenberg; Gerd Utermann
Journal:  J Lipid Res       Date:  2016-04-13       Impact factor: 5.922

3.  Farnesoid X receptor represses hepatic human APOA gene expression.

Authors:  Indumathi Chennamsetty; Thierry Claudel; Karam M Kostner; Anna Baghdasaryan; Dagmar Kratky; Sanja Levak-Frank; Sasa Frank; Frank J Gonzalez; Michael Trauner; Gert M Kostner
Journal:  J Clin Invest       Date:  2011-08-01       Impact factor: 14.808

Review 4.  Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA gene.

Authors:  Stefan Coassin; Florian Kronenberg
Journal:  Atherosclerosis       Date:  2022-05       Impact factor: 6.847

Review 5.  Lipoprotein(a) metabolism: potential sites for therapeutic targets.

Authors:  Jane Hoover-Plow; Menggui Huang
Journal:  Metabolism       Date:  2012-10-04       Impact factor: 8.694

6.  LPA and PLG sequence variation and kringle IV-2 copy number in two populations.

Authors:  Dana C Crawford; Ze Peng; Jan-Fang Cheng; Dario Boffelli; Magdalena Ahearn; Dan Nguyen; Tristan Shaffer; Qian Yi; Robert J Livingston; Mark J Rieder; Deborah A Nickerson
Journal:  Hum Hered       Date:  2008-07-09       Impact factor: 0.444

7.  A genome-wide analysis of DNA methylation identifies a novel association signal for Lp(a) concentrations in the LPA promoter.

Authors:  Stefan Coassin; Natascha Hermann-Kleiter; Margot Haun; Simone Wahl; Rory Wilson; Bernhard Paulweber; Sonja Kunze; Thomas Meitinger; Konstantin Strauch; Annette Peters; Melanie Waldenberger; Florian Kronenberg; Claudia Lamina
Journal:  PLoS One       Date:  2020-04-28       Impact factor: 3.240

8.  Genome-Wide Characterization of a Highly Penetrant Form of Hyperlipoprotein(a)emia Associated With Genetically Elevated Cardiovascular Risk.

Authors:  Stefan Coassin; Kevin Chemello; Ilya Khantalin; Lukas Forer; Patricia Döttelmayer; Sebastian Schönherr; Rebecca Grüneis; Clément Chong-Hong-Fong; Brice Nativel; Stéphane Ramin-Mangata; Antonio Gallo; Mathias Roche; Beatrix Muelegger; Christian Gieger; Annette Peters; Johannes Zschocke; Catherine Marimoutou; Olivier Meilhac; Claudia Lamina; Florian Kronenberg; Valentin Blanchard; Gilles Lambert
Journal:  Circ Genom Precis Med       Date:  2022-02-08

Review 9.  Lipoprotein(a): a promising marker for residual cardiovascular risk assessment.

Authors:  Anping Cai; Liwen Li; Ying Zhang; Yujin Mo; Weiyi Mai; Yingling Zhou
Journal:  Dis Markers       Date:  2013-10-22       Impact factor: 3.434

10.  A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms.

Authors:  Salome Mack; Stefan Coassin; Rico Rueedi; Noha A Yousri; Ilkka Seppälä; Christian Gieger; Sebastian Schönherr; Lukas Forer; Gertraud Erhart; Pedro Marques-Vidal; Janina S Ried; Gerard Waeber; Sven Bergmann; Doreen Dähnhardt; Andrea Stöckl; Olli T Raitakari; Mika Kähönen; Annette Peters; Thomas Meitinger; Konstantin Strauch; Ludmilla Kedenko; Bernhard Paulweber; Terho Lehtimäki; Steven C Hunt; Peter Vollenweider; Claudia Lamina; Florian Kronenberg
Journal:  J Lipid Res       Date:  2017-05-16       Impact factor: 5.922

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.